LB
Liberation Bioindustries, Inc.
SEC filingOther Technology · New York, NY
Amount raised$60.2Msold at filing
Total offering$101.7M$41.5M still open
Investors in the raise7count reported to the SEC
FiledDec 10, 2025first sale Nov 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Philip BoignerDirector
James MellonDirector
Etan BendheimExecutive Officer
Mark WarnerExecutive Officer, Director
Babar KhanDirector
Steven FinnDirector
Executive officers, directors and promoters as listed on the Form D.